<?xml version="1.0" encoding="utf-8"?>
<!-- generator="tx_libfeedcreator" -->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" ><channel><title>Helmholtz - Press Releases shown on Homepage</title><description>Press Releases shown on Homepage issued by the Helmholtz Association and its Helmholtz Research Centres</description><copyright>Helmholtz-Association</copyright><link>http://www.helmholtz.de/en/press/press_releases/</link><docs>http://www.helmholtz.de/</docs><lastBuildDate>Sat, 12 Jan 2013 08:26:36 +0100</lastBuildDate><managingEditor>presse@helmholtz.de (Thomas Gazlig)</managingEditor><image><url>http://www.helmholtz.de/uploads/tx_a21feeds/HG_LOGO_HELMHOLTZ_140x55_05.gif</url><title>Helmholtz - Press Releases shown on Homepage</title><link>http://www.helmholtz.de/en/press/press_releases/</link></image><language>de</language><webMaster>presse@helmholtz.de (Thomas Gazlig)</webMaster><category>Press</category><category>News</category><category>Press Releases</category><category>Helmholtz</category><category>Helmholtz-Association</category><category>Science</category><generator>tx_libfeedcreator</generator><item><title>Mars500 project – salt balance of the Mars 'astronauts'</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5990/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/ad1980bee1.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/ad1980bee1.jpg" width="200"></span><br />For 205 days in 2011, Jens Titze, Professor of Electrolyte and Circulatory Research at the University of Erlangen-Nuremberg, and his team strictly controlled the diet for the Mars500 test subjects during their virtual flight to Mars. Sometimes the selected food contained a lot of salt, sometimes very little. The unexpected result of the longest sodium metabolism study to date was that the assumption that the human body would excrete the salt within 24 hours was incorrect. Instead, the human body stores salt for much longer before releasing it – an important discovery for medical research and patient care.]]></content:encoded><pubDate>Tue, 08 Jan 2013 17:50:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5990/</guid></item><item><title>Seismic Fabric Coming on the Market</title><link>http://www.kit.edu/visit/pi_2013_12443.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/422818bc92.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/422818bc92.jpg" width="200"></span><br />In the case of earthquakes, only seconds may remain for a safe escape from buildings. Debris falling down and obstructing the escape routes may even aggravate the situation. A product developed at Karlsruhe Institute of Technology (KIT) extends the time for saving lifes by reinforcing walls and keeping off the debris. An innovative building material manufacturer now has launched the mature innovation on the market.]]></content:encoded><pubDate>Mon, 07 Jan 2013 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.kit.edu/visit/pi_2013_12443.php</guid></item><item><title>Superconductors for Efficient Wind Power Plants</title><link>http://www.kit.edu/visit/12436_12442.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/8a6b77036b.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/8a6b77036b.jpg" width="200"></span><br />An efficient, robust, and compact wind power plant with a 10 MW superconducting generator is being developed by partners from industry and science within the recently established EU project SUPRAPOWER. Superconduction enables considerable savings of energy and raw materials. Within SUPRAPOWER, researchers at KIT’s Institute for Technical Physics (ITEP) develop a rotating cryostat cooling the superconducting coils down to minus 253°C - a temperature crucial for electric current flow without resistance.]]></content:encoded><pubDate>Fri, 04 Jan 2013 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.kit.edu/visit/12436_12442.php</guid></item><item><title>A Shield Against Cancer</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-01-A-Shield-Against-Cancer.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/6df9229c1a.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/6df9229c1a.jpg" width="200"></span><br />Tumors grow more rapidly if their genetic material is not sufficiently tagged with methyl groups, as scientists from the German Cancer Research Center have discovered. Such tags in the DNA appear to act as a shield against cancer-promoting influences.]]></content:encoded><pubDate>Thu, 03 Jan 2013 11:27:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-01-A-Shield-Against-Cancer.php</guid></item><item><title>Graphene on Nickel: Electrons behave like light</title><link>http://www.helmholtz-berlin.de/pubbin/news_seite?nid=13643;sprache=en;typoid=3228</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/d77961400c.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/d77961400c.jpg" width="200"></span><br />Dr. Andrei Varykhalov and his colleagues in the group of Prof. Dr. Oliver Rader investigated at BESSY II the electronic properties of nickel coated with graphene and achieved an astonishing result. They could show that the conduction electrons of the graphene behave rather as light than as particles. Physicists had originally expected such behavior only for freestanding graphene layers which show a perfect honeycomb structure and not for graphene on nickel which disturbs the perfect hexagonal symmetry. Their results are supported by calculations of two theoretical groups using novel concepts. Their report was published yesterday evening in the open access journal, Phys. Rev. X, the new top...]]></content:encoded><pubDate>Fri, 21 Dec 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-berlin.de/pubbin/news_seite?nid=13643;sprache=en;typoid=3228</guid></item><item><title>Preventive Detention for Oxidizing Agents</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-66-Preventive-Detention-for-Oxidizing-Agents.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/00dd10e66d.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/00dd10e66d.jpg" width="200"></span><br />Oxidative stress is believed to cause a number of diseases. Up to now, it has been common practice to measure oxidative stress levels by determining the oxidation state of a small molecule called glutathione in cell extracts. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been the first to discover that cells under stress deposit their oxidized glutathione in a cellular waste repository. This protects cells from oxidative stress – and questions the validity of the conventional measuring method.]]></content:encoded><pubDate>Mon, 17 Dec 2012 11:27:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-66-Preventive-Detention-for-Oxidizing-Agents.php</guid></item><item><title>DESY and European XFEL scientists win Innovation Award</title><link>http://www.desy.de/news/@@news-view?id=4221&amp;lang=eng</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/3661d6584f.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/3661d6584f.jpg" width="200"></span><br />Gianluca Geloni, Vitali Kocharyan, and Evgeni Saldin will be awarded the Innovation Award on Synchrotron Radiation by the Association of Friends of Helmholtz-Zentrum Berlin. Together with Paul Emma from Lawrence Berkeley National Laboratory, the physicists from DESY and European XFEL will receive the prize for their invention of a self-seeding option that significantly improves X-ray free-electron lasers.]]></content:encoded><pubDate>Thu, 13 Dec 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.desy.de/news/@@news-view?id=4221&amp;lang=eng</guid></item><item><title>New insights on phagosome maturation</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/new_insights_on_phagosome_maturation/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/53366cc631.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/53366cc631.jpg" width="200"></span><br />Phagocytes ingest particles as well as pathogens from their surroundings into compartments called phagosomes. The phagosomes possess a harsh milieu with microbicidal function; therefore the phagocytes represent the first line of defense against infections. However, some intracellular pathogens, including members of mycobacterial species, manipulate the phagosomes to survive within them.]]></content:encoded><pubDate>Tue, 11 Dec 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/new_insights_on_phagosome_maturation/</guid></item><item><title>Cocktail Boosts Immune Cells in Fighting Cancer</title><link>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-65-Cocktail-Boosts-Immune-Cells-in-Fighting-Cancer.php</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/6c8e18ab9e.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/6c8e18ab9e.jpg" width="200"></span><br />Natural killer cells (or NK cells), as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered a cocktail consisting of three different immune mediators that leaves NK killer cells active over a long period of time. In mice, cocktail-boosted NK cells let tumors shrink. The cocktail was able to persistently activate human NK cells, too.]]></content:encoded><pubDate>Thu, 06 Dec 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-65-Cocktail-Boosts-Immune-Cells-in-Fighting-Cancer.php</guid></item><item><title>Solliance and Forschungszentrum Jülich join forces in thin film solar cell research</title><link>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-012-03solliance.html</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/d286e3abeb.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/d286e3abeb.jpg" width="200"></span><br />Forschungszentrum Jülich and Solliance announce a new partnership in the field of thin film photovoltaics. Solliance is a cross-border initiative by ECN, imec, Holst Centre, TNO and TU Eindhoven. With Jülich as an additional partner, Solliance grows further as R&D cluster bringing thin film solar energy technology to excellence and is ramping up its activities to gain market share internationally. Some partner companies are successful global players in their segment already. The science and technology in this field are world class in selected areas, with a track record of 15 to 30 years.]]></content:encoded><pubDate>Mon, 03 Dec 2012 15:44:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-012-03solliance.html</guid></item><item><title>X-ray analysis deciphers master regulator important for skin cancer</title><link>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4201&amp;lang=eng</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/d456374e19.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/d456374e19.jpg" width="200"></span><br />With the X-ray vision of DESY's light source DORIS, a research team from Hamburg and Iceland has uncovered the molecular structure of a master regulator central to the most deadly form of skin cancer, melanoma. The results, published in the scientific journal "Genes & Development", throw new light on the workings of the so-called Microphthalmia-associated Transcription Factor MITF, that is not only connected to skin cancer, but also to a variety of hereditary diseases where the production of the skin pigment melanin is disturbed, and to certain aspects of ageing. "Our data could provide a rational basis for the development of tailor-made drugs targeting MITF", explains first author Vivian Pogenberg from the Hamburg branch of the European Molecular Biology Laboratory (EMBL).]]></content:encoded><pubDate>Sat, 01 Dec 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4201&amp;lang=eng</guid></item><item><title>Traffic Cops of the Immune System</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/traffic_cops_of_the_immune_system/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/1fd84ec85b.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/1fd84ec85b.jpg" width="200"></span><br />Molecule called IκBNS in charge of regulatory immune cell maturation. A certain type of immune cell – the regulatory T cell, or Treg for short – is in charge of putting on the brakes on the immune response. In a way, this cell type might be considered the immune system"s traffic cop. Now, scientists at the Helmholtz Centre for Infection Research (HZI) have looked into the origin of Tregs and uncovered a central role played by the protein IκBNS.]]></content:encoded><pubDate>Thu, 29 Nov 2012 18:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/traffic_cops_of_the_immune_system/</guid></item><item><title>Asteroid dust from space</title><link>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5773/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/d6cb230eeb.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/d6cb230eeb.jpg" width="200"></span><br />To the naked eye there is nothing to see, and yet the small transparent container holds something never observed before. For the first time, scientists are studying asteroid dust collected by a spacecraft and returned to Earth. Ute Böttger, from the Institute of Planetary Research at the German Aerospace Center (Deutsches Zentrum für Luft- und Raumfahrt; DLR), belongs to one of 11 teams across the world that are carrying out scientific work on the asteroid particles from the Japanese Hayabusa mission.]]></content:encoded><pubDate>Wed, 28 Nov 2012 14:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5773/</guid></item><item><title>Sieve holds nanoparticles and acts as solar absorber</title><link>http://www.hzg.de/cms01/public_relations/press_releases/034817/index_0034817.html.en</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/a54e5381c9.jpeg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/a54e5381c9.jpeg" width="200"></span><br />A membrane consisting of polymer fibres and proteins makes a novel filter for tiny, nano-scaled particles in aqueous solutions. The result of such a research, which was done by Professor Mady Elbahri and his team from the Institute of Material Science at the Christian Albrecht University University in Kiel (CAU) and the Institue of Polymer Research at the Helmholtz-Zentrum Geestacht (HZG), has recently been published as the cover article in the current issue (21.11.2012) of "Advanced Functional Materials".]]></content:encoded><pubDate>Tue, 27 Nov 2012 09:13:44 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.hzg.de/cms01/public_relations/press_releases/034817/index_0034817.html.en</guid></item><item><title>Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis</title><link>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-26.html</link><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy paired with fewer side effects. To achieve this, a team of scientists under the leadership of Prof. Gunter Fischer (Max Planck Research Unit for Enzymology of Protein Folding, Halle/Saale, Germany) and Dr. Frank Striggow (German Center for Neurodegenerative Diseases (DZNE)) have combined two already approved pharmaceutical substances with each other using a chemical linker structure. The objectives of this combination are to ensure maximum brain cell protection on the one hand and the suppression of unwanted side effects on the other. The new class of substances has now been registered with the European Patent Office as the DZNE’s first patent in the form of a joint patent application with the Max Planck Research Unit. “The patent approval process can take several years. During this phase we are planning to conclude the pre-clinical development. It is our aim to start with clinical research and development at the earliest possible time. Overall, we have identified substantial therapeutic potential as far as chronic and age-related neurodegenerative diseases are concerned,” comments Dr. Frank Striggow.]]></content:encoded><pubDate>Mon, 26 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-26.html</guid></item><item><title>New Risk Factor Identified for High Blood Pressure during Pregnancy</title><link>http://www.mdc-berlin.de/en/news/2012/20121122-new_risk_factor_identified_for_high_blood_/index.html</link><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine. The cause of preeclampsia is still unclear. Dr. Florian Herse (Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and the Charité), Dr. Ralf Dechend (ECRC and Helios Klinikum Berlin-Buch) and their collaborators have now identified an enzyme that is overexpressed in affected women and thus apparently contributes to development of the condition. In animal experiments, the researchers inhibited this enzyme and were able to ameliorate the disease process (10.1161/CIRCULATIONAHA.112.127340)*.]]></content:encoded><pubDate>Mon, 19 Nov 2012 01:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.mdc-berlin.de/en/news/2012/20121122-new_risk_factor_identified_for_high_blood_/index.html</guid></item><item><title>Profiling X-ray free-electron laser pulses</title><link>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4061&amp;lang=eng</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/868d33800e.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/868d33800e.jpg" width="200"></span><br />With their ultra short X-ray flashes, free-electron lasers offer the opportunity to film chemical reactions or atoms in motion. However, for this super slow motion the arrival time and the temporal profile of the pulses must be precisely known. An international team of scientists has now developed a measurement technique that provides complete temporal characterization of individual FEL (free-electron laser) pulses at DESY´s soft-X-ray free-electron laser FLASH. The team, led by Adrian Cavalieri from the Center for Free-Electron Laser Science (CFEL) in Hamburg, was able to measure the temporal profile of each X-ray pulse with femtosecond precision (a femtosecond is a quadrillionth of a second). Their technique can be implemented at any of the world´s X-ray free-electron lasers, ultimately allowing for most effective utilization of these sources. The results are published in the current issue of the scientific journal &ldquo;Nature Photonics&rdquo;.]]></content:encoded><pubDate>Mon, 19 Nov 2012 00:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4061&amp;lang=eng</guid></item><item><title>Appetite suppressant for scavenger cells</title><link>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/appetite_suppressant_for_scavenger_cells/</link><enclosure url="http://www.helmholtz.de/typo3temp/pics/fb9cc10763.jpg" type="image/jpeg" length="8192"  /><source url="http://www.helmholtz.de/rss20/en/mediathek/rss_feeds/rss_feed_presseinformationen_der_startseite/?tx_a21feeds_pi1[uid]=17" >Helmholtz - Press Releases shown on Homepage</source><content:encoded><![CDATA[<span><img src="http://www.helmholtz.de/typo3temp/pics/fb9cc10763.jpg" width="200"></span><br />When infected with influenza, the body becomes an easy target for bacteria. The flu virus alters the host’s immune system and compromises its capacity to effectively fight off bacterial infections. Now, a team of immunologists at the Helmholtz Centre for Infection Research (HZI) and cooperation partners has discovered that an immune system molecule called TLR7 is partly to blame. The molecule recognizes the viral genome – and then signals scavenger cells of the immune system to ingest fewer bacteria. The researchers published their findings in the Journal of Innate Immunity.]]></content:encoded><pubDate>Thu, 15 Nov 2012 10:00:00 +0100</pubDate><category>feed_theme</category><author>online@helmholtz.de (Helmholtz-Gemeinschaft)</author><guid>http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/appetite_suppressant_for_scavenger_cells/</guid></item></channel></rss